Digitex Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 22-12-2024
- Paid Up Capital ₹ 2.58 M
as on 22-12-2024
- Company Age 29 Year, 15 Days
- Last Filing with ROC 31 Mar 2018
- Revenue 61.33%
(FY 2018)
- Profit 2003.29%
(FY 2018)
- Ebitda -129.50%
(FY 2018)
- Net Worth 3.62%
(FY 2018)
- Total Assets 10.40%
(FY 2018)
About Digitex Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.58 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Babbar, Akshay Babbar, and Abhaya Babbar serve as directors at the Company.
- CIN/LLPIN
U74899DL1995PTC074786
- Company No.
074786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 1995
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Digitex Medical Systems Private Limited offer?
Digitex Medical Systems Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, ECG Machine, Doppler Machine, Surgical & ICU Equipments, Patient Monitoring System, Pulse Oximeter, Glucometer & POCT Devices, Air Compressors, Accessories & Parts, Air Compressors, Surgical Equipments, Electrosurgical Unit.
Who are the key members and board of directors at Digitex Medical Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhaya Babbar  | Director | 31-Aug-2015 | Current |
| Ajay Babbar | Director | 20-Dec-1995 | Current |
| Akshay Babbar | Director | 18-Aug-2015 | Current |
Financial Performance of Digitex Medical Systems.
Digitex Medical Systems Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 61.33% increase. The company also saw a substantial improvement in profitability, with a 2003.29% increase in profit. The company's net worth moved up by a moderate rise of 3.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Digitex Medical Systems?
In 2018, Digitex Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Digitex Medical Systems?
Unlock and access historical data on people associated with Digitex Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Digitex Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Digitex Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
